• Joseph Corasanti has been appointed CEO of Conmed (Utica, New York), effective Jan. 1. He currently is the company's president and chief operating officer. He will succeed Eugene Corasanti, the company founder, who will continue to serve as chairman in the capacity of non-executive chairman and will relinquish his executive functions at Conmed Dec. 31 but stay with the company as vice chairman. Conmed makes surgical devices and equipment for minimally invasive procedures and monitoring for arthroscopy, powered surgical instruments, electrosurgery, cardiac monitoring disposables, endosurgery and endoscopic technologies.

• Kimball Genetics (Denver) reported the appointment of Annette Taylor, PhD, its president/CEO, to the Genomic Medicine Program Advisory Committee of the U.S. Department of Veterans Affairs, a new committee formed to help the VA develop policies for using genetic information for the medical care of veterans and to enhance development of tests and treatments for diseases common among veterans. The first of three annual meetings took place Oct. 16 in Washington DC. Kimball Genetics is a diagnostic laboratory specializing in testing for common genetic disorders.